Status:
COMPLETED
Development and Optimization of a GBS Diagnostic Test
Lead Sponsor:
Laval University
Collaborating Sponsors:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Streptococcus Group B
Eligibility:
FEMALE
18-44 years
Brief Summary
The purpose of this clinical study is to develop an easily performed test to detect Group B Streptococcus (GBS) in pregnant women at the time of delivery, which would allow health care providers to ma...
Detailed Description
Group B Streptococcus (GBS), also known as Streptococcus agalactiae, is a gram-positive diplococcus originally known for causing bovine mastitis and was not demonstrated to be a human pathogen until 1...
Eligibility Criteria
Inclusion
- Be admitted for delivery
- Be able to provide written informed consent
Exclusion
- Have vaginal bleeding
- Presence of placenta previa
- Have urgent indication to proceed to immediate delivery
- Have any condition which in the opinion of the investigator would impose a health risk to the subject or interfere with the evaluation of the GBS diagnostic
Key Trial Info
Start Date :
May 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
269 Patients enrolled
Trial Details
Trial ID
NCT00322829
Start Date
May 1 2006
End Date
March 1 2008
Last Update
February 28 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier de l'Université Laval/ CHUQ
Québec, Canada, G1V 4G2